Pharmacologic approaches to management of arrhythmias in patients with cardiomyopathy and heart failure.
Interactions between disordered cardiac rhythm and abnormal cardiac hemodynamic function are well recognized. Demonstrations of this relationship include the relationship between prognostic significance of ventricular ectopy and left ventricular ejection fraction, impairment of ventricular function in association with loss of atrial systole in disease states, increased risk of potentially lethal arrhythmias in the myopathic ventricle, and the evolution of advanced grades of ventricular arrhythmias in acute heart failure. With the development of newer and more potent antiarrhythmic agents, in conjunction with drugs that can improve the failing circulation, it is now possible to clarify these interrelationships and perhaps develop new strategies for clinical management.
Myerburg
R J
RJ
Department of Medicine, University of Miami Medical Center, FL.
Kessler
K M
KM
Zaman
L
L
Fernandez
P
P
DeMarchena
E
E
Castellanos
A
A
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D002311:Cardiomyopathy, Dilated; D006333:Heart Failure; D006801:Humans
D000889:Anti-Arrhythmia Agents